Navigation Links
Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price
Date:7/22/2010

SOUTH SAN FRANCISCO, Calif., July 22 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) announced today that on July 20, 2010 it received a letter from the Nasdaq Stock Market stating that the minimum bid price of the Company's common stock has been below $1.00 per share for 30 consecutive business days and that the Company therefore is not in compliance with the minimum bid price requirement for continued listing set forth in Marketplace Rule [5450(a)(1)].  The notification of noncompliance has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Global Market.

The Company has been provided 180 calendar days, or until January 18, 2011, to regain compliance with the minimum bid price requirement.  To regain compliance, the closing bid price of the Company's common stock must meet or exceed $1.00 per share for at least ten consecutive business days during this 180-day grace period.  Nasdaq may, in its discretion, require the Company's common stock to maintain a closing bid price of at least $1.00 for a period in excess of ten consecutive trading days, but generally no more than 20 consecutive business days, before determining that the Company has demonstrated an ability to maintain long-term compliance.

If the Company does not regain compliance by January 18, 2011, it will receive written notification from Nasdaq that its common stock is subject to delisting.  The Company may, at that time, appeal the delisting determination to a Nasdaq Hearings Panel.  Such a
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Poniard Announces Final Data from Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
2. Poniard Pharmaceuticals Announces $6.3 Million Financing
3. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
4. Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference
5. Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
6. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
7. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
8. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
9. Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
10. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
11. Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... and MECHELEN, Belgium , ... and AbbVie (NYSE: ABBV ) announced today ... include Crohn,s disease.  Galapagos will fund and complete a ... to facilitate rapid progression into Phase 3.  Upon successful ... will pay Galapagos $50 million.  The terms of the ...
(Date:5/16/2013)... RALEIGH, N.C. , May 16, 2013  Today, ... North Carolina House of Representatives recently ... coverage for chemotherapy from charging patients higher out-of-pocket fees ... IV formularies, many of which have more severe side-effects. ... out-of-pocket limit of $300, which will continue to be ...
(Date:5/16/2013)... 2013  Amgen (NASDAQ: AMGN ) will participate ... 21, 2013, at the Sheraton New York Times Square in ... a.m. Eastern Daylight Time. Joseph P. Miletich ... at Amgen, will present at the conference. Live audio of ... Amgen,s website, www.amgen.com , under Investors. A replay of ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... CryoLife, Inc. (NYSE: CRY ), ... announced today its results for the fourth quarter and the ... 2 percent to a fourth quarter record of $29.2 million ...   "We are pleased to experience yet another ...
... Feb. 17, 2011 Perrigo (Nasdaq: PRGO ; ... agreement with AgaMatrix, Inc. to sell and distribute blood glucose ... As part of the agreement, Perrigo will sell and distribute ... certain future new products. AgaMatrix is a privately held company ...
Cached Medicine Technology:CryoLife Posts Record Annual Revenues of $116.6 Million 2CryoLife Posts Record Annual Revenues of $116.6 Million 3CryoLife Posts Record Annual Revenues of $116.6 Million 4CryoLife Posts Record Annual Revenues of $116.6 Million 5CryoLife Posts Record Annual Revenues of $116.6 Million 6CryoLife Posts Record Annual Revenues of $116.6 Million 7CryoLife Posts Record Annual Revenues of $116.6 Million 8CryoLife Posts Record Annual Revenues of $116.6 Million 9CryoLife Posts Record Annual Revenues of $116.6 Million 10CryoLife Posts Record Annual Revenues of $116.6 Million 11CryoLife Posts Record Annual Revenues of $116.6 Million 12CryoLife Posts Record Annual Revenues of $116.6 Million 13CryoLife Posts Record Annual Revenues of $116.6 Million 14CryoLife Posts Record Annual Revenues of $116.6 Million 15Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products 2Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products 3
(Date:5/19/2013)... Buenos Aires, Argentina: Yoga classes ( clases de Yoga ... by the Sivananda Yoga Vedanta Center. The center ... Norte). Classes are 90 minutes and are offered all ... a calm environment, allowing visitors to enjoy the benefits ... among others. , The Yoga classes follow the following ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The legal ... website YazSideEffects.com in a concerted effort to connect women ... combination birth control drugs Yaz, Yasmin & Ocella with ... wealth of information on the notorious birth control drugs ... Bayer Pharmaceuticals. , Yaz, Yasmin & Ocella were ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Daily Gossip issued ... a new review on their page. John Colston, Daily Gossip’s ... to Shaun Hadsall’s revolutionizing 14-Day Rapid Fat Loss Plan ... sustain that carbs are healthy at a time when nutritionists ... from highly caloric products. , The diet is based ...
(Date:5/18/2013)... May 18, 2013 Also known as ... increasingly popular weight loss surgery that guarantees patients long-term ... Center wishes to give readers a brief tutorial ... attended medical school at New York City’s Mount Sinai ... Methodist he undertook a fellowship in Minimally Invasive Bariatric ...
(Date:5/18/2013)... May 18 (HealthDay News) -- Children who swallow high-powered ... remove the objects, according to a new study. ... in New Orleans, found that more than 79 percent ... either surgery or an endoscopic procedure, in which a ... tract. Only 21 percent of these cases can be ...
Breaking Medicine News(10 mins):Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3Health News:Swallowing Magnets Can Be Fatal for Children 2
... , , WOONSOCKET, R.I., ... not take their medications, but being busy or simply forgetting top the ... ten consumers (28%) sometimes forget to refill their prescriptions on time, and ... to a daily medication schedule. In addition, more than half (52%) ...
... , , , ... 13 As Americans are becoming increasingly aware of probiotics, ... and Prebiotics (ISAPP) provide increased clarity about the definition of ... percent) of Americans said they are aware of the term ...
... R.I., Aug. 13 CVS Caremark (NYSE: CVS ... examined consumer attitudes and behaviors around health care and prescription usage. ... coverage along with cost savings realized by improving health care delivery. , ... E75914LOGO ) , , Of all consumers ...
... , , , ... American Veterinary Medical Association (AVMA) is unveiling a new online pre ... multiple improvements to the tools and resources available to journalists. , , ... covering the complex and often controversial issues in veterinary medicine as easy as ...
... , ALLEGAN, Mich., Aug. 13 Perrigo ... its Board of Directors declared a quarterly dividend of $0.055 ... record on August 28, 2009. , , ... that develops, manufactures and distributes over-the-counter (OTC) and generic prescription ...
... Israel, Aug. 13 Shamir Optical Industry Ltd. (Nasdaq: ... and technology to the ophthalmic lens market, today announced unaudited financial ... , For the quarter ended June 30, 2009, revenues ... same period in 2008. The decrease in revenues was mainly due ...
Cached Medicine News:Health News:CVS/pharmacy Helping Consumers with Challenge of Filling Prescriptions on Time 2Health News:CVS/pharmacy Helping Consumers with Challenge of Filling Prescriptions on Time 3Health News:New Guidelines Provide Clarity About Probiotics 2Health News:CVS Caremark Announces Results of 2009 Health IQ Study 2Health News:CVS Caremark Announces Results of 2009 Health IQ Study 3Health News:AVMA Unveils Improved Online Press Room to Help Journalists 2Health News:AVMA Unveils Improved Online Press Room to Help Journalists 3Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 2Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 3Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 4Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 5Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 6Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 7Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 8Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 9Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 10
... readers offering 96-channel parallel detection of fluorescence, ... 1,536-well microtiter plates. Compact workstations and ... the transport of microtiter plates with a ... The need for mechanical switching required by ...
... 1495-051 96PW washes all 96 ... and automatically. Separate wash and ... and excellent washing ability. Pre-programmed ... easily removable 96-channel head reduce ...
... SkanWasher 300 with ... system. Vacuum pressure and ... heights are adjustable. On-board ... configure 8 different programs. ...
... Automatic 96-well microplate washer ... Vacuum pressure, air pressure, and ... are adjustable. On-board software for ... programs. External vacuum pump required. ...
Medicine Products: